We are live on ! Find out more
SWTX

SpringWorks Therapeutics

Delisted

SWTX was delisted on the 30th of June, 2025.

3 hedge funds and large institutions have $2.16M invested in SpringWorks Therapeutics in 2025 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 217 closing their positions.

New
Increased
Maintained
Reduced
Closed

99% less funds holding

Funds holding: 2223 (-219)

99.54% less ownership

Funds ownership: 99.59%0.05% (-100%)

100% less capital invested

Capital invested by funds: $3.53B → $2.16M (-$3.52B)

100% less funds holding in top 10

Funds holding in top 10: 180 (-18)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 217

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 2

Holders
3
Holders Change
-219
Holders Change %
-98.65%
% of All Funds
0.04%
Holding in Top 10
Holding in Top 10 Change
-18
Holding in Top 10 Change %
-100%
% of All Funds
New
Increased
Reduced
2
Closed
217
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Deutsche Bank
101
Deutsche Bank
Germany
-$2.21M -47,010 Closed
Mirae Asset Global ETFs Holdings
102
Mirae Asset Global ETFs Holdings
Hong Kong
-$2.13M -45,233 Closed
MIM
103
MetLife Investment Management
New Jersey
-$2.04M -43,379 Closed
SSA
104
Schonfeld Strategic Advisors
New York
-$2.02M -42,899 Closed
State of New Jersey Common Pension Fund D
105
State of New Jersey Common Pension Fund D
New Jersey
-$1.91M -40,705 Closed
Manulife (Manufacturers Life Insurance)
106
Manulife (Manufacturers Life Insurance)
Ontario, Canada
-$1.85M -39,318 Closed
Wells Fargo
107
Wells Fargo
California
-$1.82M -38,683 Closed
State of Wisconsin Investment Board
108
State of Wisconsin Investment Board
Wisconsin
-$1.65M -35,211 Closed
Pathstone Holdings
109
Pathstone Holdings
New Jersey
-$1.56M -33,301 Closed
HHGC
110
Hunting Hill Global Capital
New York
-$1.46M -31,119 Closed
Invesco
111
Invesco
Georgia
-$1.44M -30,672 Closed
MTCM
112
Mint Tower Capital Management
Netherlands
-$1.41M -30,000 Closed
CAU
113
Caxton Associates (UK)
-$1.36M -28,897 Closed
Wellington Management Group
114
Wellington Management Group
Massachusetts
-$1.34M -28,460 Closed
EAM
115
Erste Asset Management
Austria
-$1.28M -27,300 Closed
Universal-Beteiligungs- und Servicegesellschaft
116
Universal-Beteiligungs- und Servicegesellschaft
Germany
-$1.2M -25,590 Closed
ACM
117
ADAR1 Capital Management
Texas
-$1.13M -24,082 Closed
PA
118
Profund Advisors
Maryland
-$1.07M -22,726 Closed
ProShare Advisors
119
ProShare Advisors
Maryland
-$1M -21,336 Closed
Handelsbanken Fonder
120
Handelsbanken Fonder
Sweden
-$996K -21,200 Closed
BCM
121
BCK Capital Management
Connecticut
-$940K -20,000 Closed
GC
122
Guggenheim Capital
Illinois
-$910K -19,364 Closed
Fidelity Investments
123
Fidelity Investments
Massachusetts
-$904K -19,230 Closed
Russell Investments Group
124
Russell Investments Group
United Kingdom
-$898K -19,113 Closed
BFM
125
Boothbay Fund Management
New York
-$881K -18,750 Closed

SWTX Hedge Fund Activity: Q3 2025 in Review

3 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in SpringWorks Therapeutics (SWTX) for Q3 2025, worth a combined $2.16M — down 100% from $3.53B a quarter earlier.

Sellers outnumbered buyers: 217 funds closed out of SWTX and 0 opened new positions — a net loss of 217 holders — while 2 trimmed existing stakes and 0 added.

The largest seller was BlackRock, exiting entirely with an estimated $341M sold.

  • 3 institutional investors held SpringWorks Therapeutics (SWTX) as of Q3 2025, down from 222 in Q2 2025.
  • Funds reported $2.16M of SpringWorks Therapeutics stock for Q3 2025, down 100% quarter-over-quarter.
  • 0 funds opened new SpringWorks Therapeutics positions in Q3 2025 and 217 closed out, a net change of -217 holders.
  • The largest SpringWorks Therapeutics seller in Q3 2025 was BlackRock, an estimated $341M sold.

Based on aggregated 13F filings for Q3 2025.